Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Brunner-La Rocca

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Chest|October 14, 2003
Interaction of angiotensin-converting enzyme inhibition and aspirin in congestive heart failure: long controversy finally resolved?Hans Peter Brunner-La Rocca
International Journal of Cardiology|January 21, 2020
What do we need to better understand the role of biomarkers in heart failure?Hans-Peter Brunner-La Rocca
European Heart Journal|July 6, 2010
Towards applicability of measures of arterial stiffness in clinical routineHans-Peter Brunner-La Rocca
European Heart Journal|February 12, 2008
Do we understand why the heart fails?Hans Peter Brunner-La Rocca
Swiss Medical Weekly|March 21, 2007
End-stage chronic heart failureG Leibundgut, Hans Peter Brunner-La Rocca
European Journal of Heart Failure|May 1, 2020
Do chronic heart failure patients receive optimal decongestive interventions in a real-life setting? Letter regarding the article 'Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry'Justas Simonavicius, Hans-Peter Brunner-La Rocca
Cardiac Failure Review|August 9, 2017
Biomarker Guided Therapy in Chronic Heart FailureHans-Peter Brunner-La Rocca, Sema Bektas
European Heart Journal. Quality of Care & Clinical Outcomes|March 31, 2026
Natriuretic peptides - a screening tool for heart failure?Christof Peters, Hans-Peter Brunner-La Rocca
European Journal of Heart Failure|November 12, 2020
The importance of electrocardiographic follow-up in heart failureKevin Vernooy, Hans-Peter Brunner-La Rocca
International Journal of Cardiology|April 22, 2015
Inflammation in HFpEF: Key or circumstantial?Vanessa van Empel, Hans-Peter Brunner-La Rocca
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Chest|October 14, 2003
Interaction of angiotensin-converting enzyme inhibition and aspirin in congestive heart failure: long controversy finally resolved?Hans Peter Brunner-La Rocca
International Journal of Cardiology|January 21, 2020
What do we need to better understand the role of biomarkers in heart failure?Hans-Peter Brunner-La Rocca
European Heart Journal|July 6, 2010
Towards applicability of measures of arterial stiffness in clinical routineHans-Peter Brunner-La Rocca
European Heart Journal|February 12, 2008
Do we understand why the heart fails?Hans Peter Brunner-La Rocca
Swiss Medical Weekly|March 21, 2007
End-stage chronic heart failureG Leibundgut, Hans Peter Brunner-La Rocca
European Journal of Heart Failure|May 1, 2020
Do chronic heart failure patients receive optimal decongestive interventions in a real-life setting? Letter regarding the article 'Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry'Justas Simonavicius, Hans-Peter Brunner-La Rocca
Cardiac Failure Review|August 9, 2017
Biomarker Guided Therapy in Chronic Heart FailureHans-Peter Brunner-La Rocca, Sema Bektas
European Heart Journal. Quality of Care & Clinical Outcomes|March 31, 2026
Natriuretic peptides - a screening tool for heart failure?Christof Peters, Hans-Peter Brunner-La Rocca
European Journal of Heart Failure|November 12, 2020
The importance of electrocardiographic follow-up in heart failureKevin Vernooy, Hans-Peter Brunner-La Rocca
International Journal of Cardiology|April 22, 2015
Inflammation in HFpEF: Key or circumstantial?Vanessa van Empel, Hans-Peter Brunner-La Rocca
Pageof 31